Charlotte Nichols MP: written questions
106 published records · newest first.
Written questions
Employment: MenopauseWomen and EqualitiesTabled 18 Nov 2025AnsweredUIN 92240More
Question: To ask the Minister for Women and Equalities, what measures the Government is taking to ensure that employers are supporting women managing menopause in the workplace.
Answer: We know that support in the workplace during the menopause can be crucial. That is why we will require large employers to detail the steps they are taking to support their staff during the menopause as part of an action plan. These will be introduced on a...
Answered 26 Nov 2025
Original Parliament recordFlexible Working: WomenDepartment for Business and TradeTabled 18 Nov 2025AnsweredUIN 92239More
Question: To ask the Secretary of State for Business and Trade, what steps the Government is taking to support women in the workplace with flexible working.
Answer: Flexible working can make work more inclusive for those facing barriers to staying in and getting on at work, including women navigating parenthood, caring responsibilities, health conditions, and other personal circumstances.We are changing legislation t...
Answered 26 Nov 2025
Original Parliament recordEmployment: Sexual HarassmentWomen and EqualitiesTabled 18 Nov 2025AnsweredUIN 92238More
Question: To ask the Minister for Women and Equalities, what steps the Government is taking to ensure employers are taking a proactive and preventative approach to protecting their employees from workplace sexual harassment.
Answer: On 26 October 2024, the Worker Protection (Amendment to the Equality Act 2010) Act 2023 came into force. This inserted a new section 40A into the Equality Act 2010 which requires employers to anticipate the risk of sexual harassment occurring and take ste...
Answered 26 Nov 2025
Original Parliament recordPublic Sector: ProcurementCabinet OfficeTabled 18 Nov 2025AnsweredUIN 92237More
Question: To ask the Minister for the Cabinet Office, what steps he is taking to ensure that public contracts are not awarded to companies that blacklist workers.
Answer: This Government is committed to ensuring public procurement supports British jobs and industry. Under the exclusion regime in the Procurement Act 2023, contracting authorities may exclude suppliers for blacklisting offences. The exclusion regime came into...
Answered 26 Nov 2025
Original Parliament recordCoronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88871More
Question: To ask the Secretary of State for Health and Social Care, when the database of AstraZeneca covid-19 vaccine side effects was last updated.
Answer: The Medicines and Healthcare products Regulatory Agency is responsible for monitoring all authorised medicines and vaccines in the United Kingdom, including the AstraZeneca COVID-19 vaccines, on an ongoing basis to ensure their benefits continue to outwei...
Answered 20 Nov 2025
Original Parliament recordVaccine Damage Payment SchemeDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88870More
Question: To ask the Secretary of State for Health and Social Care, what comparative assessment he has made of approval rates for covid-19 vaccine injury claims in (a) the UK and (b) other jurisdictions for which figures are available.
Answer: No specific assessment has been made. All claims made through the Vaccine Damage Payment Scheme are assessed on a case-by-case basis by independent medical assessors. Medical assessors must be General Medical Council registered doctors with a licence to p...
Answered 18 Nov 2025
Original Parliament recordVaccine Damage Payment SchemeDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88869More
Question: To ask the Secretary of State for Health and Social Care, what the rate for (a) approval of claims, (b) claims overturned at review and (c) payout has been for the Vaccine Damage Payment Scheme since March 2022.
Answer: The Vaccine Damage Payment Scheme (VDPS) provides a one-off, tax-free payment of £120,000 to claimants who have been found, in rare cases and on the balance of probabilities, to have been severely disabled by certain vaccines for a disease listed in the V...
Answered 18 Nov 2025
Original Parliament recordVaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88868More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to make (a) apheresis and (b) immunoabsorption treatments available for vaccine damage patients when doctors feel it would be beneficial.
Answer: In the very rare event where an individual may have suffered a severe adverse reaction to a COVID-19 vaccine, care and treatment will be managed by National Health Service local specialist services, augmented as appropriate by national specialist advice, ...
Answered 19 Nov 2025
Original Parliament recordCoronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88867More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) approve and (b) fund specialist treatments for AstraZeneca vaccine damage.
Answer: In the very rare event where an individual may have suffered a severe adverse reaction to a COVID-19 vaccine, care and treatment will be managed by National Health Service local specialist services, augmented as appropriate by national specialist advice, ...
Answered 19 Nov 2025
Original Parliament recordCoronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88866More
Question: To ask the Secretary of State for Health and Social Care, whether his Department is undertaking research into (a) damage and (b) lasting effects from the AstraZeneca vaccine.
Answer: Vaccines are only authorised once they have met robust standards of effectiveness, safety, and quality set by the independent medicines’ regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).The monitoring of vaccine safety does not st...
Answered 18 Nov 2025
Original Parliament recordVaccine Damage Payment SchemeDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88865More
Question: To ask the Secretary of State for Health and Social Care, what the medical experience requirements are for caseworkers handling vaccine damage payment claims.
Answer: Caseworkers supporting the Vaccine Damage Payment Scheme (VDPS) are administrative staff who are not involved in the assessment of claims. Their role is to provide claimants with a consistent point of contact, manage the administrative progress of claims,...
Answered 18 Nov 2025
Original Parliament recordCoronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88864More
Question: To ask the Secretary of State for Health and Social Care, how often the database of AstraZeneca covid vaccine side effects has been updated in each year since 2020.
Answer: The Medicines and Healthcare products Regulatory Agency is responsible for monitoring all authorised medicines and vaccines in the United Kingdom, including the AstraZeneca COVID-19 vaccines, on an ongoing basis to ensure their benefits continue to outwei...
Answered 20 Nov 2025
Original Parliament recordCoronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88863More
Question: To ask the Secretary of State for Health and Social Care, what research his Department is undertaking into side affects of the AstraZenica covid vaccine; through what process his Department are recognising emerging side effects; and if he will make a stat
Answer: Vaccines are only authorised once they have met robust standards of effectiveness, safety, and quality set by the independent medicines’ regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).The monitoring of vaccine safety does not st...
Answered 18 Nov 2025
Original Parliament recordNuclear Decommissioning Authority: Redundancy PayDepartment for Energy Security and Net ZeroTabled 10 Nov 2025AnsweredUIN 88862More
Question: To ask the Secretary of State for Energy Security and Net Zero, what discussions he had with the Group Chief Executive Officer of the Nuclear Decommissioning Authority on the implementation of that organisation's voluntary exit scheme before it was introd
Answer: Details of Ministers' and Permanent Secretaries' meetings with external individuals and organisations are published quarterly in arrears on GOV.UK. As part of this approach, the NDA has introduced voluntary exit schemes across its group to support organis...
Answered 18 Nov 2025
Original Parliament recordTrawsfynydd Power Station: DecommissioningDepartment for Energy Security and Net ZeroTabled 10 Nov 2025AnsweredUIN 88861More
Question: To ask the Secretary of State for Energy Security and Net Zero, whether his Department has carried out an assessment of the potential impact of the Nuclear Decommissioning Authority estate's voluntary exit scheme on the (a) delivery of objectives and (b)
Answer: The Nuclear Decommissioning Authority (NDA) remains focused on delivering its statutory mission to keep former nuclear sites safe and secure while progressing decommissioning and managing waste. To achieve this efficiently, the NDA has introduced voluntar...
Answered 18 Nov 2025
Original Parliament recordKetamineHome OfficeTabled 4 Nov 2025AnsweredUIN 87846More
Question: To ask the Secretary of State for the Home Department, if she will make an assessment of the potential impact of the reclassification of ketamine as a class B drug on (a) the rate of its usage among (i) 16 to 59-year-olds and (ii) 16 to 24-year-olds, (b)
Answer: My reply to my honourable friend's previous questions as to what assessment the Home Office had made of the potential impact of the reclassification of ketamine on these four matters confirmed that we had not carried out such an exercise and that the driv...
Answered 18 Nov 2025
Original Parliament recordNuclear Decommissioning AuthorityDepartment for Energy Security and Net ZeroTabled 4 Nov 2025AnsweredUIN 87845More
Question: To ask the Secretary of State for Energy Security and Net Zero, whether his Department has made an economic assessment of the potential impact of the Nuclear Decommissioning Authority estate's current voluntary exit scheme on the regional economy in (a) W
Answer: The NDA remains committed to supporting communities in each of these areas to build a resilient, inclusive future by investing in skills, wellbeing, infrastructure, and economic diversification that create lasting opportunities beyond decommissioning.The ...
Answered 17 Nov 2025
Original Parliament recordNuclear Decommissioning AuthorityDepartment for Energy Security and Net ZeroTabled 4 Nov 2025AnsweredUIN 87844More
Question: To ask the Secretary of State for Energy Security and Net Zero, whether his Department has assessed the potential impact of the Nuclear Decommissioning Authority estate's current voluntary exit scheme on the achievement of that organisation's mission.
Answer: The outcome of the recent Spending Review settlement reflects the government’s recognition of the NDA’s critical role in safeguarding the UK’s nuclear legacy. This funding will enable the NDA to continue to perform its core mission, ensuring safe and secu...
Answered 17 Nov 2025
Original Parliament recordNuclear Decommissioning Authority: Redundancy PayDepartment for Energy Security and Net ZeroTabled 4 Nov 2025AnsweredUIN 87843More
Question: To ask the Secretary of State for Energy Security and Net Zero, what is the estimated cost to the public purse of the current voluntary exit scheme at the Nuclear Decommissioning Authority's estate.
Answer: The cost of the voluntary exit schemes across the NDA group will vary according to the level of exits mutually agreed between employers and members of staff.
Answered 17 Nov 2025
Original Parliament recordCervical Cancer: ScreeningDepartment of Health and Social CareTabled 30 Oct 2025AnsweredUIN 86736More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of cervical cancer self-sampling on reaching under-screened populations; and what targets he has for the uptake of (a) in-clinic and
Answer: Both the impact assessment and the equality impact assessment on the introduction of human papillomavirus (HPV) self-sampling for the under-screened population in the National Health Service Cervical Screening Programme have been published and is availabl...
Answered 5 Nov 2025
Original Parliament recordCervical Cancer: Health ServicesDepartment of Health and Social CareTabled 30 Oct 2025AnsweredUIN 86735More
Question: To ask the Secretary of State for Health and Social Care, with reference to NHS England's plan entitled Cervical cancer elimination by 2040 – plan for England, published on 28 March 2025, if his Department will set out (a) who is responsible for each of t
Answer: The Government is committed to improving vaccine uptake and access across all immunisation programmes by exploring new and innovative delivery models, including expanding routes such as community pharmacies, as set out in the NHS Vaccination Strategy and ...
Answered 1 Dec 2025
Original Parliament recordObesity: Prescription DrugsDepartment of Health and Social CareTabled 30 Oct 2025AnsweredUIN 86734More
Question: To ask the Secretary of State for Health and Social Care, if he will make it his policy that weight loss injections can only be prescribed following a face-to-face meeting with a GP who can determine that the patient (a) does not have too low a BMI and (b
Answer: The Department is considering how the current prescribing system operates in relation to patient access to medicines through private, or non-National Health Service, routes. This includes online prescribing. A call for evidence was launched in August 2025...
Answered 10 Nov 2025
Original Parliament recordFinancial Services: Tax EvasionTreasuryTabled 29 Oct 2025AnsweredUIN 86321More
Question: To ask the Chancellor of the Exchequer, what estimate her Department has made of the annual cost to HMRC through the facilitation of tax evasion by the financial services sector.
Answer: HM Revenue and Customs (HMRC) estimate the size of the tax gap, which is the difference between the amount of tax that should, in theory, be paid to HMRC, and what is actually paid. The tax gap statistics and details of the estimate methodologies are publ...
Answered 7 Nov 2025
Original Parliament recordKetamine: MisuseHome OfficeTabled 15 Oct 2025AnsweredUIN 82395More
Question: To ask the Secretary of State for the Home Department, what assessment her Department has made of the potential impact of the reclassification of ketamine as a class B drug on its illicit availability.
Answer: Ketamine is a dangerous substance, which can cause irreversible bladder damage and in some cases death. Ministers are very concerned about the harms ketamine causes and on 16 October 2025 the Department for Health and Social Care launched a campaign to al...
Answered 27 Oct 2025
Original Parliament recordKetamine: MisuseHome OfficeTabled 15 Oct 2025AnsweredUIN 82394More
Question: To ask the Secretary of State for the Home Department, what assessment her Department has made of the potential impact of the reclassification of ketamine as a class B drug on the average street price of ketamine annually since 2015.
Answer: Ketamine is a dangerous substance, which can cause irreversible bladder damage and in some cases death. Ministers are very concerned about the harms ketamine causes and on 16 October 2025 the Department for Health and Social Care launched a campaign to al...
Answered 27 Oct 2025
Original Parliament record
Published records only — not a full account of an MP’s work. How we work →